Studies Point to Three Health Dangers Associated with Fosamax

Fosamax is a prescription drug which is commonly used for the prevention of bone loss due to abnormally low bone mass density which may potentially trigger osteoporosis. It is a pill which should be taken everyday by osteoporotic men and women. Osteoporosis is a bone disease which robs the bone from its essential mineral, which makes the bone weak and brittle and thus increasing the rate of fractures. However, just like any other type of drugs, Fosamax is also associated with serious side effects which several doctors found it to be alarming, according to media reports. The complaints of the number of injured osteoporotic individuals have resulted Fosamax injury lawsuits. The article may help you understand more about the health risk related to Fosamax.

Femur Fracture

There have been many reports that long-term use of Fosamax (alendronate) is associated with strange events of femur fractures. The fractures were low-energy fractures, meaning that they all occurred from a fall from standing height or less, and the bone cracks were in an unusual horizontal pattern. About one-third of women with these types of fractures were on long-term therapy to prevent osteoporosis, the researchers noted. Of these women, two-thirds were taking Fosamax (alendronate), for an average of more than seven years.

Osteonecrosis of the Jaw

Another serious side-effect of Fosamax is the osteonecrosis of the jaw. Osteonecrosis of the jaw is a condition wherein the jaw fails to heal after a minor injury. However, until now, there is still no clear connection as to why osteonecrosis of the jaw occurs in a person who is taking Fosamax. The best estimate of risk is 0.1 percent, meaning the condition occurs in one in every 1,000 women taking Fosamax over the course of a year.

Esophageal Cancer

Reports have it that bone-building drugs, such as Fosamax, may double the risk of developing esophageal cancers in osteoporotic patients. However, studies still have not found evidences linking Fosamax to esophageal cancers. But the use of Fosamax has been related to the inflammation of the esphagus in patients who failed to use the medication incorrectly.

In 2008, the Food and Drug Administration (FDA) have given warning to all healthcare providers that bisphosphonate drugs, such as Fosamax, may cause severe bone, joint and muscle pain. While some people who have several of the risk factors and a history of previous bone fractures may benefit from taking Fosamax, other people may be able to prevent osteoporosis with healthy lifestyle changes involving diet and exercise. To know more about more related cases, you may visit Fosamax Injury Lawsuit Center at fosamaxinjurylawsuitcenter.com.

ABOUT THE AUTHOR

The author works as an online medical researcher focusing on bisphosphonate drugs. One of the major subjects that the author is currently working on is about the safety issues of Fosamax in osteoporotic individuals.NULL This article is copyright protected.

Author: Kathleen Hennis